t>

Eli Lilly and Company is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, The Wall Street Journal reports

[ad_1]


Eli Lilly and Company is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, The Wall Street Journal reports

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *